These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6956652)

  • 1. Enhanced D-galactosamine hepatotoxicity after propylthiouracil treatment in the rat.
    Mihas TA; Ceballos R; Hirschowitz BI; Gibson RG; Mihas AA
    J Med; 1982; 13(1-2):71-9. PubMed ID: 6956652
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of partial hepatectomy on the hepatotoxicity of D-galactosamine.
    Andreicuţ S; Kerekes M
    Morphol Embryol (Bucur); 1982; 28(2):177-84. PubMed ID: 6213854
    [No Abstract]   [Full Text] [Related]  

  • 3. Potentiation of hepatotoxicity by ethanol in galactosamine-induced hepatitis in rats: role of propylthiouracil protection.
    Nadkarni GD; Naik SB; Talavdekar RV; Soman CS; Talwalkar GV; Ganatra RD
    Acta Pharmacol Toxicol (Copenh); 1983 Feb; 52(2):90-4. PubMed ID: 6846026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proceedings: The hepatotoxic effect of ethanol after pretreatment with carbon tetrachloride, allyl alcohol, or D-galactosamine.
    Strubelt O; Buettner F; Siegers CP
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R102. PubMed ID: 1170506
    [No Abstract]   [Full Text] [Related]  

  • 5. An investigation of the hepatotoxicity of D-galactosamine in different species of animal.
    James GW; Pickering RW; Parker FL
    Arzneimittelforschung; 1975 Oct; 25(10):1593-4. PubMed ID: 1243045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of Alpha-tocopherol on the hepatotoxicity of D-galactosamine.
    Mihas AA; Doos W; Gibson RG; Hirschowitz BI
    Ala J Med Sci; 1976 Oct; 13(4):384-7. PubMed ID: 984338
    [No Abstract]   [Full Text] [Related]  

  • 7. Ameliorative effect of an urinary preparation on acetaminophen and D-galactosamine induced hepatotoxicity in rats.
    Lai TY; Wu YW; Lin WC
    Am J Chin Med; 1999; 27(1):73-81. PubMed ID: 10354819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lipid metabolism and liver function in D-galactosamine poisoning in rats].
    Vengerovskiĭ AI; Saratikov AS
    Patol Fiziol Eksp Ter; 1988; (3):52-5. PubMed ID: 3174253
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of chronic ethanol ingestion on liver and plasma protein synthesis in galactosamine-induced hepatitis in rats.
    Nadkarni GD; Pestonjamasp KN; Deshpande UR
    Acta Pharmacol Toxicol (Copenh); 1983 Aug; 53(2):92-5. PubMed ID: 6684872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycine and uridine prevent D-galactosamine hepatotoxicity in the rat: role of Kupffer cells.
    Stachlewitz RF; Seabra V; Bradford B; Bradham CA; Rusyn I; Germolec D; Thurman RG
    Hepatology; 1999 Mar; 29(3):737-45. PubMed ID: 10051475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of preliminary fasting on the development of D-galactosamine-induced acute lesion of the liver in rats].
    Adzharov D; Donchev N; Kerimova M; Naĭdenova E; Borov B
    Biull Eksp Biol Med; 1989 Jan; 107(1):33-6. PubMed ID: 2914170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The anti-hepatotoxic effect of parenterally administered silymarin in galactosamine hepatitis of the rat].
    Schriewer H; Rausen HM
    Arzneimittelforschung; 1973 Jan; 23():Suppl:159. PubMed ID: 4740687
    [No Abstract]   [Full Text] [Related]  

  • 13. [Specific hepatotoxic effect of D-galactosamine].
    Andreicut S; Kerekes M
    Morphol Embryol (Bucur); 1977; 23(3):221-5. PubMed ID: 142915
    [No Abstract]   [Full Text] [Related]  

  • 14. ["Galactosamine refractory" regenerating liver--a model for studies on the etiology mechanism of galactosamine hepatitis].
    Reutter W; Bauer C; Bachmann W; Lesch R
    Hoppe Seylers Z Physiol Chem; 1972 May; 353(5):747. PubMed ID: 5069316
    [No Abstract]   [Full Text] [Related]  

  • 15. Investigations on d-galactosamine hepatitis after pretreatment with alpha-hexachlorocyclohexane.
    Schuchhardt C; Reutter W; Lesch R
    Beitr Pathol; 1976 Feb; 157(1):45-55. PubMed ID: 57771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimethadione as a model drug for the evaluation of hepatic drug-metabolizing capacity in normal and D-galactosamine intoxicated rats.
    Tanaka E; Kinoshita H; Yoshida T; Kuroiwa Y
    Jpn J Pharmacol; 1982 Dec; 32(6):1182-5. PubMed ID: 7161969
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in polyamine metabolism of rat liver after administration of D-galactosamine. Favorable effects of putrescine administration on galactosamine-induced hepatic injury.
    Daikuhara Y; Tamada F; Takigawa M; Takeda Y; Mori Y
    Gastroenterology; 1979 Jul; 77(1):123-32. PubMed ID: 447009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of the hepatotoxicity of D-galactosamine in the rat by an anti-endotoxin.
    Mihas AA; Ceballos R; Mihas TA; Hirschowitz BI
    J Med; 1990; 21(6):301-11. PubMed ID: 2093097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of essential phospholipids on the galactosamine hepatitis in rats].
    Petzold H; Titlbach O
    Cesk Gastroenterol Vyz; 1974 Apr; 28(3):178-80. PubMed ID: 4447983
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of single or consecutive administration of T-2588 on hepatic-injured male rats].
    Shimotori T; Shibata T; Nakagawa S; Sato S; Nagai A; Yoneda T
    Jpn J Antibiot; 1986 Sep; 39(9):2307-23. PubMed ID: 3795480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.